Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Miguel Verdelho
Soluble Urokinase-Type Plasminogen Activator Receptor as a Biomarker for Focal Segmental Glomerulosclerosis; A Retrospective Analysis
Journal of Nephropathology
Nephrology
Related publications
Soluble Urokinase-Type Plasminogen Activator Receptor Is a Novel Biomarker Predicting Acute Exacerbation in COPD
International Journal of COPD
Environmental
Public Health
Health Policy
Medicine
Pulmonary
Respiratory Medicine
Occupational Health
Soluble Urokinase-Type Plasminogen Activator Receptor Is a Novel Biomarker Predicting Acute Exacerbation in COPD
Circulating Soluble Urokinase-Type Plasminogen Activator Receptor in Obstructive Sleep Apnoea
Medicina
Medicine
Soluble Urokinase-Type Plasminogen Activator Receptor in Black Americans With CKD
Clinical Journal of the American Society of Nephrology
Epidemiology
Nephrology
Critical Care
Transplantation
Intensive Care Medicine
Urinary Soluble Urokinase Receptor Levels Are Elevated and Pathogenic in Patients With Primary Focal Segmental Glomerulosclerosis
BMC Medicine
Medicine
Urokinase Type Plasminogen Activator Receptor Expression in Colorectal Neoplasms
Gut
Gastroenterology
Ligand Binding Regions in the Receptor for Urokinase-Type Plasminogen Activator
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Soluble Urokinase Plasminogen Activator Receptor: A Risk Factor for Carotid Plaque, Stroke, and Coronary Artery Disease
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing
Plasminogen Activator Urokinase Receptor (PLAUR; uPAR; suPAR)
Science-Business eXchange